Search Within

Charles L Sawyers

Formats
  1. Journal Article (142)
  2. Meeting Abstract (64)
  3. Book Section (11)
  4. Review (3)
  5. Editorial (2)
  6. Miscellaneous (2)
  7. Book Whole (1)
  8. Correspondence (1)
  9. Guidelines (1)
  10. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (228)
  2. Department of Medicine (228)
  3. Executive Committee, Center for Hematologic Malignancies (228)
  4. GSK Faculty (228)
  5. Hematologic Malignancies, Division of (228)
  6. Human Oncology and Pathogenesis Program (228)

More Groups

People
  1. Howard Scher (43)
  2. John Wongvipat (41)
  3. Yu Chen (38)
  4. Brett Carver (32)
  5. Wouter Karthaus (29)
  6. Anuradha Gopalan (28)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (22)

More Years

Publications
  1. Cancer Research (31)
  2. Journal of Clinical Oncology (17)
  3. Cancer Cell (11)
  4. Proceedings of the National Academy of Sciences of the United States of America (11)
  5. Nature (8)
  6. Cancer Discovery (7)

More Publications

Publishers
  1. American Association for Cancer Research (51)
  2. Nature Publishing Group (28)
  3. American Society of Clinical Oncology (22)
  4. Cell Press (21)
  5. National Academy of Sciences (11)
  6. American Association for the Advancement of Science (8)

More Publishers

Results (228)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN
    Journal Article

    Vivanco, I.; Palaskas, N.; Tran, C.; Finn, S. P.; Getz, G.; Kennedy, N. J.; Jiao, J.; Rose, J.; Xie, W.; Loda, M.; more...
    Cancer Cell (2007)

    Fulltext@MSK | Save
  • Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
    Journal Article

    Shah, N. P.; Skaggs, B. J.; Branford, S.; Hughes, T. P.; Nicoll, J. M.; Paquette, R. L.; Sawyers, C. L.
    Journal of Clinical Investigation (2007)

    Fulltext@MSK | Save
  • Where lies the blame for resistance - Tumor or host?
    Journal Article

    Sawyers, C. L.
    Nature Medicine (2007)

    Fulltext@MSK | Save
  • Cancer: Mixing cocktails
    Journal Article

    Sawyers, C. L.
    Nature (2007)

    Fulltext@MSK | Save
  • Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer
    Journal Article

    Mehrian-Shai, R.; Chen, C. D.; Shi, T.; Horvath, S.; Nelson, S. F.; Reichardt, J. K. V.; Sawyers, C. L.
    Proceedings of the National Academy of Sciences of the United States of America (2007)

    Fulltext@MSK | Save
  • Nineteenth Annual Pezcoller Symposium: Hypothesis-driven clinical investigation in cancer
    Journal Article

    Kaelin, W. G.; Sawyers, C. L.; Mihich, E.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
    Journal Article

    Jiao, J.; Wang, S.; Qiao, R.; Vivanco, I.; Watson, P. A.; Sawyers, C. L.; Wu, H.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90
    Journal Article

    Gorre, M. E.; Ellwood-Yen, K.; Chiosis, G.; Rosen, N.; Sawyers, C. L.
    Blood (2002)

    Fulltext@MSK | Save